The latest closing stock price for Stoke Therapeutics as of November 20, 2024 is 11.31.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-558 today, roughly -1 times their original investment - a -15.05% compound annual growth rate over 5 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 55.4% above the current share price.
The Stoke Therapeutics 52-week low stock price is 3.77, which is 66.7% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 10.83.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-558 today, roughly -1 times their original investment - a -15.05% compound annual growth rate over 5 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 55.4% above the current share price.
The Stoke Therapeutics 52-week low stock price is 3.77, which is 66.7% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 10.83.